144 related articles for article (PubMed ID: 8370652)
1. Expression behavior of 85-kDa membrane protein in adriamycin-resistant tumor cells and the inhibition of human tumor growth in athymic mice by MRK-20 monoclonal antibody against the protein.
Ishii S; Naito M; Tsuruo T
Jpn J Cancer Res; 1993 Jul; 84(7):776-82. PubMed ID: 8370652
[TBL] [Abstract][Full Text] [Related]
2. Enhancement by recombinant human interferon alfa of the reversal of multidrug resistance by MRK-16 monoclonal antibody.
Fogler WE; Pearson JW; Volker K; Ariyoshi K; Watabe H; Riggs CW; Wiltrout RH; Longo DL
J Natl Cancer Inst; 1995 Jan; 87(2):94-104. PubMed ID: 7707396
[TBL] [Abstract][Full Text] [Related]
3. Reversal of drug resistance in a human colon cancer xenograft expressing MDR1 complementary DNA by in vivo administration of MRK-16 monoclonal antibody.
Pearson JW; Fogler WE; Volker K; Usui N; Goldenberg SK; Gruys E; Riggs CW; Komschlies K; Wiltrout RH; Tsuruo T
J Natl Cancer Inst; 1991 Oct; 83(19):1386-91. PubMed ID: 1681110
[TBL] [Abstract][Full Text] [Related]
4. Regression of established tumors expressing P-glycoprotein by combinations of adriamycin, cyclosporin derivatives, and MRK-16 antibodies.
Watanabe T; Naito M; Kokubu N; Tsuruo T
J Natl Cancer Inst; 1997 Apr; 89(7):512-8. PubMed ID: 9086008
[TBL] [Abstract][Full Text] [Related]
5. An M(r) 7-kDa membrane protein overexpressed in human multidrug-resistant ovarian cancer cells.
Yang X; Pagé M
Cancer Lett; 1995 Jan; 88(2):171-8. PubMed ID: 7874690
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a new monoclonal antibody F4 detecting cell surface epitope and P-glycoprotein in drug-resistant human tumor cell lines.
Chu TM; Kawinski E; Lin TH
Hybridoma; 1993 Aug; 12(4):417-29. PubMed ID: 7503940
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16 and synergistic modulation of multidrug resistance.
Naito M; Tsuge H; Kuroko C; Koyama T; Tomida A; Tatsuta T; Heike Y; Tsuruo T
J Natl Cancer Inst; 1993 Feb; 85(4):311-6. PubMed ID: 7678867
[TBL] [Abstract][Full Text] [Related]
8. [Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16, and their synergistic modulation of multidrug resistance].
Naito M; Tsuruo T
Gan To Kagaku Ryoho; 1994 Feb; 21(3):395-402. PubMed ID: 7906507
[TBL] [Abstract][Full Text] [Related]
9. Expression of 85-kDa protein of adriamycin-resistant tumor cells during hematopoietic differentiation of THP-1 and HEL cells.
Ishii S; Naito M; Masuda M; Tsuruo T
Jpn J Cancer Res; 1992 Jan; 83(1):107-12. PubMed ID: 1371989
[TBL] [Abstract][Full Text] [Related]
10. A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16.
Weiner LM; Holmes M; Adams GP; LaCreta F; Watts P; Garcia de Palazzo I
Cancer Res; 1993 Jan; 53(1):94-100. PubMed ID: 8093231
[TBL] [Abstract][Full Text] [Related]
11. Cellular and tissue distribution of MRK20 murine monoclonal antibody-defined 85-kDa protein in adriamycin-resistant cancer cell lines.
Sugawara I; Ohkochi E; Hamada H; Tsuruo T; Mori S
Jpn J Cancer Res; 1988 Oct; 79(10):1101-10. PubMed ID: 2904427
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of multidrug-resistant human tumor growth in athymic mice by anti-P-glycoprotein monoclonal antibodies.
Tsuruo T; Hamada H; Sato S; Heike Y
Jpn J Cancer Res; 1989 Jul; 80(7):627-31. PubMed ID: 2571602
[TBL] [Abstract][Full Text] [Related]
13. Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically multidrug-resistant human colorectal carcinoma cell lines in the nude mouse model.
Iwahashi T; Okochi E; Ariyoshi K; Watabe H; Amann E; Mori S; Tsuruo T; Ono K
Cancer Res; 1993 Nov; 53(22):5475-82. PubMed ID: 8106147
[TBL] [Abstract][Full Text] [Related]
14. In vivo imaging and specific targeting of P-glycoprotein expression in multidrug resistant nude mice xenografts with [125I]MRK-16 monoclonal antibody.
Scott AM; Rosa E; Mehta BM; Divgi CR; Finn RD; Biedler JL; Tsuruo T; Kalaigian H; Larson SM
Nucl Med Biol; 1995 May; 22(4):497-504. PubMed ID: 7550027
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effect of adriamycin entrapped in liposomes conjugated with monoclonal antibody against tumor-associated antigen of bovine leukemia cells.
Onuma M; Odawara T; Watarai S; Aida Y; Ochiai K; Syuto B; Matsumoto K; Yasuda T; Fujimoto Y; Izawa H
Jpn J Cancer Res; 1986 Nov; 77(11):1161-7. PubMed ID: 3025145
[TBL] [Abstract][Full Text] [Related]
16. [Target therapy by monoclonal antibody against ovarian carcinoma conjugated with liposomes and adriamycin].
Li WJ; Qian HN; Lu WY
Zhonghua Yi Xue Za Zhi; 1994 Sep; 74(9):539-41, 582. PubMed ID: 7842351
[TBL] [Abstract][Full Text] [Related]
17. A cell surface antigen (BAL) defined by a mouse monoclonal antibody inducing apoptosis in a human lymphocytic leukemia cell line.
Wallén-Ohman M; Borrebaeck CA
Int J Cancer; 1994 May; 57(4):544-52. PubMed ID: 8181858
[TBL] [Abstract][Full Text] [Related]
18. Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies.
Hamada H; Tsuruo T
Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7785-9. PubMed ID: 2429319
[TBL] [Abstract][Full Text] [Related]
19. [Target therapy by monoclonal antibody against ovarian carcinoma conjugated with liposome and adriamycin].
Li WJ; Qian HN; Lu WY
Zhonghua Fu Chan Ke Za Zhi; 1994 May; 29(5):296-8, 319. PubMed ID: 7956556
[TBL] [Abstract][Full Text] [Related]
20. Detection of 300-kilodalton membrane protein in adriamycin-resistant human tumor cells by a monoclonal antibody MRK18.
Sugimoto Y; Okochi E; Hamada H; Oh-hara T; Tsuruo T
Biochem Biophys Res Commun; 1990 Jun; 169(2):686-91. PubMed ID: 1972622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
